Ipsen
Ipsen SA engages in the research, development, manufacture, and sale of pharmaceutical products worldwide.
Launch date
Employees
Market cap
CAD13.1b
Enterprise valuation
CAD12.7b (Public information from Sep 2024)
Share price
€111.9 IPN.PA
Boulogne-Billancourt Île-de-France (HQ)
No columns specified